Haleon has officially launched Centrum across Pakistan, marking a significant milestone as the world’s No.1 multivitamin ...

British consumer healthcare group Haleon on Tuesday said it gained full control of its Chinese joint venture after acquiring ...

Settlement may compensate consumers who bought Robitussin cough medicine products that were falsely marketed as "non-drowsy." ...

Consumers who bought a popular cough syrup could be eligible for money as part of a class action settlement. Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the ...

Haleon PLC closed 10.34% below its 52-week high of £4.18, which the company achieved on March 4th.

Anyone in the U.S. who bought any flavor Robitussin product containing dextromethorphan (or DXM) and labeled as “non-drowsy” between Feb. 16, 2016, and Jan. 21 are eligible to file a claim, according ...

Critics say this violates the principle of shareholder democracy and makes it harder for investors to hold boards to account.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a report released today, Cedric Besnard from Citi maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...

Kepler Capital analyst Karel Zoete maintained a Buy rating on Haleon PLC (HLN – Research Report) on April 8 and set a price target of p440.00.

Haleon PLC closed 11.52% short of its 52-week high of £4.18, which the company reached on March 4th.